Award

Role of fibroblast-specific TGF-beta effects in fibrosis and dysfunction of the aging heart.

Description: Heart failure is one of the major causes of hospitalizations and deaths in the elderly. In these patients, heart failure with preserved ejection fraction remains as the most common form of heart failure. Accumulating evidence shows that progressive structural and functional changes occur in the heart as it ages, a process known as cardiac aging, which leads to functional decline and culminates in development of heart failure. Cardiac aging is associated with myocardial fibrosis that contributes to increased myocardial stiffness, which together with impaired relaxation creates the basis for development of diastolic dysfunction observed in elderly patients. Aging-associated myocardial fibrosis involves phenotypic changes in cardiac fibroblasts, the major cells responsible for collagen production and extracellular matrix remodeling. The cytokine transforming growth factor beta (TGFb) is a central mediator of fibrosis in many pathologic conditions, through activation of downstream signaling receptor-activated Smads, or Smad-independent cascades. Because pathways typically activated by aging, such as oxidative stress and neurohumoral cascades, are known to induce and activate TGFb signaling, I speculate that TGFb may play an essential role in aging-associated cardiac fibrosis. Whether TGFb-mediated activation of fibroblasts is involved in the pathogenesis of fibrosis and cardiac dysfunction in the aging heart is poorly understood. This proposal will use cardiac fibroblast-specific knockout mice and a broad range of in vivo and in vitro assays to explore for the first time the role and regulation of fibroblast TGFb signaling in the aging heart. Our preliminary data demonstrates that in the aging heart there is accentuated activation of TGFb receptors, Smads proteins, as well as increased fibroblast transcription of TGFb target profibrotic genes. Thus, I hypothesize that age-associated dysregulation of cardiac fibroblast TGFb cascades contributes to the development of myocardial fibrosis and diastolic dysfunction observed in the aging heart. This will be studied by 3 specific aims. Aim 1 will examine the pattern of expression and activation of TGFb in the aging heart. Aim 2 will investigate the role of fibroblast-specific TGFb signaling in age-associated cardiac fibrosis and diastolic dysfunction. Aim 3 will dissect the molecular mechanism involved in fibroblast specific TGFb effects in the aging heart.
Amount: $231,000
Funding type: fellowship
Funder scheme: Career Development Award
Start date: 2023-04-01
End date: 2026-03-31
Field: Medicine
Funded outputs count: 0
Funder award ID: 23CDA1051156
OpenAlex ID: G2232065652